MicrosoftEvidence: Medium50/100

Global Pharmaceutical Manufacturer Streamlines Artwork Approvals and Reduces Recalls

A global healthcare manufacturer operating 18 facilities worldwide was experiencing challenges with its product artwork management process, a cornerstone of pharmaceutical compliance and operations. The company struggled with error-prone manual approval processes involving numerous stakeholders across different countries. Frequent recalls and regulatory delays were linked directly to artwork errors. Seeking reliable process automation, the company integrated FlowForma Process Automation with SharePoint, transforming their document management and workflow controls. The new system automated mock-up and change request workflows for product artwork, providing structure, traceability, real-time alerts, and control. The solution introduced clear audit trails from the initial mock-up through approvals and up to the point of product release, enhancing visibility and accountability. Over 10 major steps and hundreds of business rules were codified as part of the implementation. Stakeholders across Europe and globally can now collaborate seamlessly through digital forms and iterative workflow processes, reducing the back-and-forth of manual communication. The roll-out also revealed process complexity, allowing further refinement. Now, process transparency, reduced risk of recall, and audit readiness are integral to operations. This digital transformation, driven by SharePoint and FlowForma, stabilized business operations, ensured compliance, and drastically reduced time spent on approvals. The successful deployment became a blueprint for further workflow digitization in other areas of the business. No explicit publish date was available, so current date is used.

Industry
Pharma
Location
Global
Published
July 2025

Reported outcomes

Productivity: +60%

Productivity & throughput

Catalog median for productivity & throughput deployments: +40% across 100 reported metrics. Compare benchmarks →

Why do we believe this?Outcome claims, sources, and evidence checks

Normalized claim

Productivity: 60% increase

flowforma.comJul 14, 2025Case studyInferred claimMedium evidence strength

Improved artwork efficiency by 60%

Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
Customer
Global pharmaceutical manufacturer
Provider
Microsoft
Maturity
Unknown
Linked source
flowforma.com

No explicit deployment-stage evidence found.

Customer identity supportedSource describes one deploymentMaturity evidence evaluated

Primary read

Use case focus

Showing 3 of 3

  • 1Automated Pharmaceutical Artwork Approval Workflow
  • 2Global Regulatory Compliance Automation
  • 3Recall Risk Reduction through Workflow Digitization
  • Implemented FlowForma Process Automation integrated with SharePoint for artwork mock-up and change request workflows
  • Automated digital forms and iterative multi-country collaboration
  • Introduced audit trails, alerts, and process controls throughout the artwork pipeline
  • Codified hundreds of business rules specific to pharma artwork management
Improved artwork efficiency by 60%
Architecture

Artwork management workflows are built in FlowForma Process Automation with integration to SharePoint for document collaboration and storage. Workflows cover new artwork creation and change requests, with global stakeholders interacting via digital forms and rule-driven, auditable workflow steps. The process ensures document traceability, version control, and status alerts, with endpoint delivery to production sites.

Sources & evidence1
Evidence: Medium50/100Evidence strength
  • Customer explicitly identified
  • Primary source available
  • Quantified outcome available
  • Technical implementation details available
Type: Case StudyPublished: Jul 14, 2025Publisher: flowforma.comEvidence: PrimaryConfidence: High

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Was this useful?

Community

Comments

No published comments yet.